UBS raised the firm’s price target on Varonis (VRNS) to $65 from $60 and keeps a Buy rating on the shares. Varonis reported strong Q2 results with a “well-rounded” SaaS contribution, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VRNS:
- Varonis price target raised to $50 from $47 at DA Davidson
- Varonis Systems: Buy Rating Affirmed Amid Strong Q2 Performance and Strategic SaaS Transition
- Varonis price target raised to $62 from $60 at Barclays
- Varonis Systems: Strong Growth and SaaS Transition Justify Buy Rating
- Varonis Systems Reports Strong SaaS Growth in Q2 2025